Evaluation of a chromogenic agar under development to screen for VRE colonization

Journal of Clinical Microbiology

Volumn 48, Issue 3, 2010, Pages 999-1001

  Kallstrom, George ^a   Doern, Christopher D ^a   Dunne Jr , W Michael ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR MEDIUM; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIUM DETECTION; BBL CHROMAGAR VANCOMYCIN RESISTANT ENTEROCOCCUS; BILE ESCULIN AZIDE AGAR PLUS VANCOMYCIN; CONTROLLED STUDY; DISEASE CONTROL; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; EVALUATION RESEARCH; FECES; HIGH RISK PATIENT; HOSPITAL INFECTION; INTERMETHOD COMPARISON; NONHUMAN; PREDICTION AND FORECASTING; PRIORITY JOURNAL; SCREENING; SENSITIVITY AND SPECIFICITY; VANCOMYCIN RESISTANT ENTEROCOCCUS;

AGAR; BACTERIOLOGICAL TECHNIQUES; CARRIER STATE; CHROMOGENIC COMPOUNDS; CULTURE MEDIA; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY; VANCOMYCIN RESISTANCE;

ENTEROCOCCUS; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM;

EID: 77749255766     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.02011-09     Document Type: Article

References (7)

1. Ledeboer, N. A., R. J. Tibbetts, and W. M. Dunne. 2007. A new chromogenic agar medium, chromID VRE, to screen for vancomycin-resistant Enterococcus faecium and Enterococcus faecalis. Diagn. Microbiol. Infect. Dis. 59:477-479.
2. Bonten, M. J., S. Slaughter, A. W. Ambergen, M. K. Hayden, J. van Voorhis, C. Nathan, and R. A. Weinstein. 1998. The role of "colonization pressure" in the spread of vancomycin-resistant enterococci: an important infection control variable. Arch. Intern. Med. 158:1127-1132.
3. Russell, D. L., A. Flood, T. E. Zaroda, C. Acosta, M. M. Riley, R. W. Busuttil, and D. A. Pegues. 2008. Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am. J. Transplant. 8:1737-1743.
4. Weber, S. G., S. S. Huang, S. Oriola, W. C. Huskins, G. A. Noskin, K. Harriman, R. N. Olmsted, M. Bonten, T. Lundstrom, M. W. Climo, M. C. Roghmann, C. L. Murphy, and T. B. Karchmer. 2007. Legislative man-dates for use of active surveillance cultures to screen for methicillinresistant Staphylococcus aureus and vancomycin-resistant enterococci: position statement from the Joint SHEA and APIC Task Force. Am. J. Infect. Control 35:73-85.
5. Winn, W. C., and E. W. Koneman. 2006. Streptococci, enterococci and the streptococcus-like bacteria, p. 672-764. Koneman's color atlas and textbook of diagnostic microbiology, 6th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
6. Worth, L. J., K. A. Thursky, J. F. Seymour, and M. A. Slavin. 2007. Vancomycin-resistant Enterococcus faecium infection in patients with hematologic malignancy: patients with acute myeloid leukemia are at high-risk. Eur. J. Haematol. 79:226-233.
7. Zaas, A. K., X. Song, P. Tucker, and T. M. Perl. 2002. Risk factors for development of vancomycin-resistant enterococcal bloodstream infection in patients with cancer who are colonized with vancomycin-resistant enterococci. Clin. Infect. Dis. 35:1139-1146.